January 13, 2021 After a big year, biotech flotations have much to do Whether investor enthusiasm for drug stocks holds up this year is the burning question for IPO followers.
January 07, 2021 Covid or not, venture financing breaks records Private biotechs attracted more venture cash in 2020 than in any other year of the current cycle.
August 17, 2020 With a following wind JW looks to go public The Juno/Wuxi venture will soon become one of just a few Chinese cell therapy players with a stock exchange listing.
July 10, 2020 Venture investors: biotech's preppers? A handful of huge financings helped start-ups raise a record $5.4bn in the second quarter as investors brace for tougher times.